Fusing anti-inflammatory drugs with antibodies that are specific to damaged arthritic cartilage shows promise as a targeted therapy for rheumatoid arthritis in a mouse study.
from Bones / Orthopedics News From Medical News Today http://ift.tt/1mkiud8
from Bones / Orthopedics News From Medical News Today http://ift.tt/1mkiud8